Loading…
Jiangxi-based new-materials company; specific product line not established from available knowledge.
Jiangxi-based new-materials company; specific product line not established from available knowledge.
Moat: none
Headquarters: Jiangxi, China · Employees: 1,622
Size Jiangxi Hungpai New Material (605366.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $821M, the 2695th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥7.08 on 6 Nov 2026.
Performance Over six months the shares fell 46.9%, against -19.6% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 2.0% over the last twelve months (peer median +6.5%); the operating margin is -11.2% (peer median 10.3%).
Valuation It trades at 236.0× forward earnings against a peer median of 21.4× (most expensive of 15).
Capital Return on invested capital runs 12.6 points below its cost of capital (8.7% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.51B | CN¥1.39B | CN¥1.48B | CN¥1.38B | CN¥1.69B |
| Revenue growth | — | -6% | +7% | -19% | — |
| Gross profit | CN¥23.0M | CN¥22.8M | CN¥129M | CN¥178M | CN¥560M |
| EBITDA | CN¥47.5M | CN¥46.9M | CN¥153M | CN¥179M | CN¥446M |
| Net income | -CN¥150M | -CN¥146M | -CN¥30.9M | CN¥65.0M | CN¥352M |
| Free cash flow | -CN¥549M | -CN¥499M | CN¥172M | -CN¥265M | -CN¥425M |
| Capital expenditure | CN¥459M | CN¥419M | CN¥103M | CN¥459M | CN¥777M |
| Total debt | CN¥987M | CN¥1.56B | CN¥1.61B | CN¥710M | CN¥557M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 605366.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -35.9% | -14.1% | 3rd lowest of 21 |
| 6-month return | -46.9% | -19.6% | 2nd lowest of 21 |
| Distance from 52-week high | -52.5% | -39.4% | 4th lowest of 21 |
| Revenue growth (TTM) | +2.0% | +6.5% | 8th lowest of 21 |
| Operating margin | -11.2% | 10.3% | 2nd lowest of 21 |
| Forward P/E | 236.0× | 21.4× | most expensive of 15 |
| ROIC minus cost of capital | -12.6 pp | -2.5 pp | 3rd lowest of 21 |
| Net debt / EBITDA | -2.1× | -0.7× | 2nd least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangxi Hungpai New Material 605366.SS | China | $821M | -47% | +2% | -11% | 236.0× | n/a | n/a |
| Sanyo Chemical Industries 4471.T | Japan | $823M | +24% | 0% | 10% | 10.5× | -5.1% | -2.5% |
| Polyrocks Chemical 688669.SS | China | $831M | +40% | -8% | -6% | n/a | 35.9% | +15.2% |
| Xinyaqiang Silicon Chemistry 603155.SS | China | $788M | -6% | +6% | 10% | 37.0× | 31.1% | +3.9% |
| Raghav Productivity Enhancers RPEL.NS | India | $864M | +133% | +38% | 28% | n/a | n/a | n/a |
| Suzhou Highfine Biotech 301393.SZ | China | $865M | -8% | +36% | 17% | 32.3× | n/a | n/a |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $776M | +6% | -1% | 1% | 41.5× | 45.3% | +26.0% |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $870M | -41% | +8% | -7% | n/a | n/a | n/a |
| Daxin Materials 5234.TW | Taiwan | $767M | -42% | +10% | 19% | 25.7× | 17.7% | +1.5% |
| JCU 4975.T | Japan | $759M | -26% | +2% | 40% | 13.6× | 6.3% | +7.0% |
| KH Neochem 4189.T | Japan | $732M | +20% | -11% | 12% | 12.3× | -5.7% | +8.3% |
| Zhejiang Huangma Technology 603181.SS | China | $935M | -30% | +7% | 17% | 14.5× | n/a | n/a |
| Liaoning Oxiranchem,Inc 300082.SZ | China | $716M | -39% | +4% | 0% | 35.1× | n/a | n/a |
| Jubilant Ingrevia JUBLINGREA.NS | India | $966M | -24% | +15% | 10% | 21.1× | 27.3% | +44.9% |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $981M | -28% | -30% | 17% | n/a | 8.8% | +11.6% |
| Jiansu Huachang Chemical 002274.SZ | China | $679M | -25% | +9% | -3% | 5.7× | 23.6% | +1.3% |
| Ningxia Zhongke Biotechnology 600165.SS | China | $679M | -19% | +8% | -73% | n/a | n/a | n/a |
| Shandong Sanyuan Biotechnology 301206.SZ | China | $676M | -18% | +15% | 4% | n/a | n/a | n/a |
| Caregen 214370.KS | South Korea | $1.01B | -73% | -8% | 24% | 22.6× | 35.2% | +3.8% |
| Shandong Yanggu Huatai Chemical 300121.SZ | China | $648M | -20% | +11% | 8% | 16.1× | 3.2% | +12.1% |
| Victrex VCT.L | United Kingdom | $1.04B | +54% | -1% | 14% | 21.7× | 15.7% | +1.9% |